Guangdong Biolight Meditech Co., Ltd. (SHE:300246)
China · Delayed Price · Currency is CNY 14.99
-0.02 (-0.13%)
Sep 4, 2026, 3:04 PM CST
SHE:300246 Revenue
Guangdong Biolight Meditech had revenue of 274.74M CNY in the quarter ending June 30, 2026, a decrease of -0.35%. This brings the company's revenue in the last twelve months to 1.09B, up 4.64% year-over-year. In the year 2025, Guangdong Biolight Meditech had annual revenue of 1.10B with 3.29% growth.
Revenue (ttm)
1.09B
Revenue Growth
+4.64%
P/S Ratio
3.60
Revenue / Employee
816.25K
Employees
1,335
Market Cap
3.92B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.10B | 34.91M | 3.29% |
| Dec 31, 2024 | 1.06B | -133.52M | -11.18% |
| Dec 31, 2023 | 1.19B | 10.30M | 0.87% |
| Jan 1, 2023 | 1.18B | 92.68M | 8.49% |
| Jan 1, 2022 | 1.09B | -305.00M | -21.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| GKHT Medical Technology | 6.47B |
| Zhejiang Orient Gene Biotech | 1.01B |
| Guangdong Transtek Medical Electronics | 999.28M |
| Shanghai Aohua Photoelectricity Endoscope | 793.05M |
| Hangzhou AGS MedTech | 592.88M |
| Ningbo David Medical Device | 584.68M |
| Nanjing Vishee Medical Technology | 478.71M |
| Medprin Regenerative Medical Technologies | 400.85M |